Hawaii Cannabis Regulations
Legal for Medical Use OnlyRegulatory Agency: Department of Health (DOH) · ·
1. Cannabis Landscape Overview
As of 2026, Hawaii maintains a strictly medical-only cannabis market. The state’s medical cannabis program was established by the passage of Act 241 in 2015, which authorized the creation of a dispensary system. Following the initial rollout, the first licensed medical cannabis dispensaries began operations in 2017. The program is governed by the Hawaii Department of Health (DOH), specifically the Medical Cannabis Dispensary Licensing Program (MCDLP).
The Hawaii market is characterized by a limited-license structure. Under current statutes, the state permits a maximum of eight dispensary licensees, each authorized to operate up to two production centers and two retail dispensaries, for a total of 16 retail locations statewide. As of 2026, the market serves approximately 35,000 to 40,000 registered patients. The market size remains constrained by the lack of adult-use legalization, despite recurring legislative efforts to transition the state toward a recreational model. Because Hawaii is an island chain, the market is geographically isolated, preventing the cross-border logistical efficiencies seen in mainland states. The current regulatory environment emphasizes patient safety, supply chain security, and strict adherence to the DOH’s administrative rules found in Hawaii Administrative Rules (HAR) Title 11, Chapter 850.
2. Packaging Requirements
Under HAR §11-850, all medical cannabis must be sold in packaging that is child-resistant, tamper-evident, and opaque. Packaging must not be attractive to children, meaning no cartoons, bright colors, or images that resemble candy or snack food branding. All containers must be resealable if they contain multiple servings. Materials must be of food-grade quality and must not leach harmful substances into the product. The DOH requires that all labels be permanently affixed and legible.
Packaging by Product Type
- Flower: Must be sold in opaque, child-resistant containers that prevent the degradation of cannabinoids. As of 2026, Hawaii applies the general packaging rules above to flower without additional product-specific requirements.
- Pre-rolls: Must be sold in child-resistant tubes or containers. As of 2026, Hawaii applies the general packaging rules above to pre-rolls without additional product-specific requirements.
- Edibles: Packaging must be clearly marked to distinguish it from non-cannabis food items and must be child-resistant for every individual serving or the entire container.
- Concentrates: Must be contained in non-stick, child-resistant vessels that prevent leakage and contamination.
- Vape Cartridges: Must be sold in child-resistant packaging that protects the integrity of the oil and prevents accidental discharge.
Penalties for Non-Compliance
The DOH employs a tiered enforcement strategy for packaging violations. Initial offenses typically result in a Notice of Violation and a mandated corrective action plan. Repeat violations can lead to administrative fines ranging from $1,000 to $10,000 per violation, depending on the severity and intent. Under HAR §11-850-101, the DOH reserves the authority to initiate license suspension or revocation proceedings if a licensee demonstrates a pattern of non-compliance that poses a risk to public health, particularly regarding child-safety standards.
3. Labeling Requirements
Labeling in Hawaii is highly regulated to ensure transparency for patients. Every package must display the universal cannabis symbol (a triangle containing the letters "THC") to indicate the product contains medical cannabis. Labels must include the name and license number of the production center, the batch number, the date of manufacture, and the net weight or volume. Potency must be listed as total THC and total CBD content in milligrams. An ingredient list, including any allergens or additives (such as terpenes or thinning agents in vapes), is mandatory. All products must be registered in the state’s tracking system, currently utilizing Metrc, and the label must reflect the unique identifier generated by the system.
4. Exit Bag Requirements
At the point of sale, Hawaii dispensaries are required to place all purchased medical cannabis products into an "exit bag." This bag must be opaque and child-resistant. The purpose of the exit bag is to ensure that once a patient leaves the dispensary premises, the product is shielded from public view and is inaccessible to children. Dispensaries must provide these bags at no additional cost to the patient. Compliance with these standards is verified during routine DOH inspections of retail facilities.
5. Advertising & Marketing Rules
Marketing is severely restricted in Hawaii to prevent exposure to minors. Advertisements are prohibited on television, radio, or in public spaces such as billboards or transit hubs. Digital advertising is permitted only if the website utilizes robust age-gating technology to ensure that 100% of the audience is verified as being over the age of 21 (or the legal medical age). Businesses may maintain a website for informational purposes, but it cannot contain "call to action" pricing or promotional language that could be construed as encouraging recreational use. All marketing materials must be approved by the DOH before distribution.
6. Promotional Product Rules
The distribution of free cannabis or promotional items that contain cannabis is strictly prohibited. Branded merchandise, such as apparel, lighters, or grinders, may be sold or given away, provided they do not display images or text that would appeal to minors. Co-branding with non-cannabis entities is discouraged and subject to strict DOH review to ensure the association does not imply the products are safe for children or meant for non-medical use. Promotional items must not contain any health claims not verified by the FDA or DOH.
7. Licensing Overview
The DOH manages the Medical Cannabis Dispensary Licensing Program. Licenses are issued as "vertically integrated" licenses, meaning each licensee must operate both production and retail facilities. The application process is highly competitive and occurs only when the DOH determines that patient access necessitates the expansion of the program. Fees for application and annual renewal are substantial, often exceeding $75,000 for initial licensing and significant annual renewal costs to cover the state’s regulatory oversight expenses.
8. Testing & Lab Requirements
All cannabis products must undergo rigorous testing by a state-certified independent laboratory before being released for sale. Testing categories include potency analysis (THC/CBD/terpene profile), residual solvents, heavy metals, pesticides, microbials, and moisture content. If a batch fails any safety test, it must be destroyed or remediated according to DOH protocols. Labs must be licensed by the state and maintain ISO 17025 accreditation to ensure the validity of their analytical results.
9. Possession & Purchase Limits
Under HRS §329D-12, a qualifying patient or their primary caregiver may purchase and possess up to four ounces of "usable cannabis" over a period of 15 consecutive days. This limit applies to the total weight of flower, concentrates, and infused products combined. The DOH has established specific conversion formulas to calculate the "usable cannabis" equivalent for non-flower products. For instance, one gram of concentrate may be calculated as a specific weight of flower for the purpose of the 4-ounce limit. These limits apply to Hawaii residents with a valid 329 registration card. Non-residents with reciprocity must meet specific state requirements to be recognized, though Hawaii’s current law remains focused on state-registered patients. Transfer of cannabis between individuals is prohibited, as the product is legally restricted to the registered patient.
10. Home Cultivation Rules
Home cultivation is exclusively permitted for registered medical cannabis patients or their designated primary caregivers under HRS §329-122. A patient may possess up to 10 cannabis plants at any one time. The plants must be grown in an enclosed, locked facility that is not visible from public view. Plants must be labeled with the patient's registration number. Cultivation is subject to landlord approval if the patient is a tenant, and homeowners associations may also impose restrictions. Penalties for exceeding the 10-plant limit or for failing to secure the grow area can result in the loss of medical status and criminal prosecution under state drug laws.
11. Impaired Driving / Cannabis DUI Laws
Hawaii enforces an impairment-based standard for driving under the influence of cannabis (HRS §291E-61). Unlike some states, Hawaii does not have a specific "per-se" blood THC limit (e.g., 5ng/mL) that automatically triggers a DUI conviction. Instead, law enforcement relies on the observations of a Drug Recognition Expert (DRE) and evidence of impaired driving. Implied consent laws apply: by operating a vehicle in Hawaii, drivers consent to testing. Refusal to submit to testing results in an immediate license revocation. Penalties for DUI are severe, including mandatory license suspension, fines, and potential jail time. Commercial drivers are held to a zero-tolerance standard for any detectable amount of intoxicating substances.
12. Public Consumption Rules
The public use of medical cannabis is strictly prohibited in Hawaii (HRS §329D-11). Consumption is illegal in all parks, beaches, sidewalks, schools, government buildings, and within any vehicle, regardless of whether it is moving or parked. Consumption on federal land (such as National Parks or military bases) is a federal offense. Hawaii does not currently permit licensed consumption lounges. Public consumption can lead to citations, fines, or arrest. Because Hawaii has robust anti-smoking laws (the Hawaii Smoke-Free Law), smoking cannabis in any area where tobacco smoking is prohibited is also a violation of public health statutes.
13. City-Level Local Ordinances
While the DOH sets statewide standards, local counties (Honolulu, Hawaii, Maui, and Kauai) exercise authority over zoning.
- Honolulu: Has the strictest zoning, requiring dispensaries to be located in industrial zones with significant buffers (typically 750–1,000 feet) from schools, playgrounds, and youth centers.
- Maui: Has implemented local land-use policies that restrict the number of dispensaries per district, effectively creating a cap on density.
- Hawaii County: Requires additional local permits for production centers, focusing on environmental impact and water usage, which is a significant concern on the Big Island.
14. Cross-State Transport & Airport Rules
It is illegal to transport cannabis across state lines, including into Hawaii from the mainland or between the islands, as it violates federal law (Controlled Substances Act). Hawaii airports are under the jurisdiction of the TSA and local law enforcement. While TSA’s primary focus is security, they will report any discovered cannabis to local police. There are no "amnesty boxes" at Hawaii airports for cannabis disposal. Attempting to transport cannabis, even with a valid medical card, can result in the confiscation of the product and potential criminal charges.
15. Recent & Pending Legislation
In the 2025–2026 session, the Hawaii Legislature saw several bills (e.g., SB 1234, HB 567) aimed at legalizing adult-use, but these remained in committee or failed to pass the Senate. The primary focus of the 2026 session has been the "medical-only" enhancement, specifically looking at expanding the list of qualifying conditions and streamlining the registration process for patients. No voter ballot initiatives for legalization were certified for the 2026 election cycle as of mid-year.
16. Market Size & Industry Statistics
As of 2026, annual medical cannabis sales in Hawaii are estimated at approximately $120–$140 million. The industry employs roughly 800–1,000 individuals across cultivation, processing, and retail. Key operators include MSOs and local entities such as Cure Oahu, Aloha Green, and Pono Life. Tax revenue is collected at both the state and local levels, though the lack of a recreational market keeps total tax collection well below mainland states with similar population sizes.
Cannabis Taxes in Hawaii (2026)
Hawaii cannabis businesses collect and remit multiple overlapping taxes. Below is a summary of the rates that apply to retail cannabis sales as of 2026. Regulatory agency: Hawaii Department of Health.
- Excise tax: No cannabis excise tax
- Sales tax: 4% state general excise tax (GET) applies to medical cannabis + typical 0.5% county surcharge
- Local cannabis tax: County GET surcharge (0.5% in Honolulu) applies
- Medical exemption: Hawaii is medical-only; all sales are to qualifying patients
- Effective combined rate: 4–4.5% medical combined
Hawaii uses the general excise tax (GET) rather than a sales tax; there is no cannabis-specific excise.
Get Hawaii rule-change alerts
We monitor Hawaii cannabis packaging and labeling rules — leave your email and we'll flag changes.
Hawaii Regulations by Category
📦 Packaging Requirements
Hawaii Packaging Requirements
Child-resistant, tamper-evident, opaque packaging. Cannot resemble commercially marketed candy. Plain containers.
Citation: Haw. Rev. Stat. § 329D
🏷️ Labeling Requirements
Hawaii Labeling Requirements
THC/CBD content per serving and total. Batch ID, dispensary name. Warning statement and universal symbol required.
Citation: Haw. Rev. Stat. § 329D
🛍️ Exit Bag Requirements
Hawaii Exit Bag Requirements
All medical cannabis products must be dispensed in opaque, child-resistant exit packaging per DOH rules.
Citation: HRS §329D-6
📢 Advertising & Marketing
Hawaii Advertising Rules
Medical cannabis advertising limited to dispensary premises and websites. No mass media advertising. Must include DOH license number.
Citation: HRS §329D-9
🔥 Promotional Products
Hawaii Promotional Product Rules
Medical only. No advertising visible to general public. No promotional merchandise. Marketing restricted to dispensary premises and age-gated digital.
Citation: Haw. Rev. Stat. § 329D-6
📋 Licensing Overview
Hawaii Licensing Overview
DOH issues medical cannabis dispensary licenses (vertically integrated). Adult-use legalized 2024 with licensing framework pending.
Citation: Haw. Rev. Stat. § 329D
🔬 Testing & Lab Requirements
Hawaii Testing Requirements
Mandatory potency, pesticide, heavy metal, microbial, mycotoxin, and residual solvent testing at DOH-certified laboratories.
Citation: HAR § 11-850-73
📡 Seed-to-Sale Tracking
Hawaii Seed-to-Sale Tracking
BioTrack seed-to-sale system. All medical cannabis tracked from cultivation through dispensary sale. Electronic manifests for all transfers.
Citation: Haw. Rev. Stat. § 329D-7